1. Brill-Edwards P, Ginsberg J, Johnston M, et al. Establishing a therapeutic range for heparin therapy. Ann Intern Med. 1993;119:104-109.
2. Mackinlay N, Favaloro E, Arthur C, et al. A survey of heparin monitoring in Australasia. Pathology. 1996;28:343-347.
3. Hull RD, Pineo GF, Stein P. Heparin and low molecular weight heparin therapy for venous thromboembolism: the twilight of anticoagulant monitoring [editorial]. Int Angiol. 1998;17:213-224.
4. College of American Pathologists. Comprehensive Coagulation Survey. 1995 Set GC2-A. Participant Summary. Northfield, IL: College of American Pathologists; 1995.
5. Olson JD, Arkin CF, Brandt JT, et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin. Arch Pathol Lab Med. 1998;122: 782-798.